New Zealand markets close in 3 hours 55 minutes

Green Cross Health Limited (GXH.NZ)

NZSE - NZSE Delayed price. Currency in NZD
Add to watchlist
0.8000+0.0200 (+2.56%)
As of 11:58AM NZST. Market open.
Currency in NZD

Valuation measures4

Market cap (intra-day) 112.01M
Enterprise value 233.19M
Trailing P/E 9.32
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.22
Price/book (mrq)0.73
Enterprise value/revenue 0.46
Enterprise value/EBITDA 5.13

Trading information

Stock price history

Beta (5Y monthly) 0.02
52-week change 3-41.79%
S&P500 52-week change 324.13%
52-week high 31.3600
52-week low 30.7100
50-day moving average 30.8902
200-day moving average 31.0605

Share statistics

Avg vol (3-month) 313.39k
Avg vol (10-day) 316.51k
Shares outstanding 5143.6M
Implied shares outstanding 6149.13M
Float 844.51M
% held by insiders 177.87%
% held by institutions 10.13%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.04
Forward annual dividend yield 45.13%
Trailing annual dividend rate 30.05
Trailing annual dividend yield 35.77%
5-year average dividend yield 44.38
Payout ratio 471.67%
Dividend date 3N/A
Ex-dividend date 406 Jun 2024
Last split factor 21.01:1
Last split date 331 Aug 2009

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 2.33%
Operating margin (ttm)6.21%

Management effectiveness

Return on assets (ttm)4.99%
Return on equity (ttm)8.59%

Income statement

Revenue (ttm)503.92M
Revenue per share (ttm)3.51
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA 37.49M
Net income avi to common (ttm)12.03M
Diluted EPS (ttm)0.0800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)23.4M
Total cash per share (mrq)0.16
Total debt (mrq)144.58M
Total debt/equity (mrq)86.78%
Current ratio (mrq)0.91
Book value per share (mrq)1.08

Cash flow statement

Operating cash flow (ttm)45.96M
Levered free cash flow (ttm)24.34M